• July Clinical News and Product Briefs

    Clinical Informatics News | News and product briefs from around the industry, including major new investments on patient-centered outcomes research in PCORI and the first public healthcare system to reimburse non-invasive prenatal testing.

    Jul 29, 2015

  • Is the system rigged against drugs for newly-diagnosed cancers

    Boston Business Journal | ​Researchers from the Massachusetts Institute of Technology says current systems make pharmaceutical firms "underinvest" in early-stage cancer drugs.

    Jul 29, 2015

  • Serious Risks About Existing Drugs Aren’t Given to Trial Participants

    Pharmalot | New research finds some serious risks are not disclosed on consent forms given to trial participants for studies involving approved drugs.

    Jul 29, 2015

  • Not All Fake Medicines Are Created Equal

    Washington Post | As more studies confirm that different placebos may have stronger or weaker placebo effects, scientists raise questions about how to compare the efficacy of real drugs across trials that used varying placebos.

    Jul 28, 2015

  • HelpAround Explores the Social Aspects of Mobile Health

    Clinical Informatics News | With stripped-down mHealth apps like Alert and Diabetes Helpers, Tel Aviv-based HelpAround wants to use the real-time data and location tracking of mobile technology to tap into chronic disease patients' own social networks.

    Jul 27, 2015

  • Faulty Bioequivalence Studies Lead to Hundreds of Drug Suspensions in Europe

    WSJ Pharmalot | The European Union has accepted a recommendation to suspend hundreds of drugs that were authorized for use based on what regulators called "flawed" studies conducted by GVK Biosciences, a clinical research organization based in Hyderabad, India.

    Jul 27, 2015

  • GlaxoSmithKline Sues Tibco Software Over Risk Monitoring Software

    Triangle Business Journal | ​GlaxoSmithKline has accused a California-based software developer of violating federal copyright law by selling a custom software package that was allegedly created in partnership with GSK.

    Jul 22, 2015

  • Made-In-Singapore Cancer Drug Advances To Clinical Trials

    Asian Scientist Magazine | ETC-159, a Wnt-targeting anti-cancer drug indicated for colorectal, ovarian and pancreatic cancers, has entered a Phase I clincial trial.

    Jul 20, 2015

  • HIPAA’s Use as Code of Silence Often Misinterprets the Law

    New York Times | The protection of a patient's health information does not prohibit health care providers from sharing information with family, friends and caregivers.

    Jul 17, 2015

  • FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials

    Xconomy | Blueprint Medicines got the green light from the Food and Drug Administration to begin clinical trials on its two lead drug candidates for cancer, about two months after its IPO.

    Jul 13, 2015

  • After Celgene Deal Juno Revs Armored CAR For Ovarian Cancer Trial

    Xconomy | Juno Therapeutics has built remarkable momentum and is about to launch the first trial in humans of engineered T cells.

    Jul 10, 2015

  • Concerns and Skepticism Around 21st Century Cures Act

    Washington Post | While some measures in the bipartisan 21st Century Cures Act, like increased NIH funding, have attracted widespread praise, other measures threaten to weaken the safety and efficacy evidence needed for drugs to pass muster with the FDA.

    Jul 10, 2015

  • Hospital ICUs Mine Big Data in Push for Better Outcomes

    WSJ | Leading hospitals such as Beth Israel Deaconess Medical Center in Boston and Johns Hopkins Medicine in Baltimore look for clues in the wealth of information from past cases.

    Jul 9, 2015

  • Do No Harm

    Vox | An investigation into heart line catheter infections reveals the harm analysis strategies that let hospitals prevent deadly medical errors.

    Jul 9, 2015

  • Consulting Merger Creates Certara Strategic Consulting

    Clinical Informatics News | Certara has merged its consulting group, Pharsight Consulting Services (PCS), with Quantitative Solutions, a global pharmacometrics consulting company headquartered in Menlo Park, Calif. forming Certara Strategic Consulting. Jaap Mandema, former CEO of Quantitative Soutions, will serve as the new head of Certara Strategic Consulting. Financial details were not disclosed.

    Jul 8, 2015

  • UCSD Asks Court to Restore Custody and Control of Alzheimer’s Data

    Xconomy | In the recent donnybrook between UC San Diego and the University of Southern California, the 24-year old Alzheimer's Disease Cooperative Study is what's at stake.

    Jul 8, 2015